Science Sparks @ ACTREC
02ndDecember 2024Publications
- 1. Shinghal A, Pradhan S, Chopra S, Kapoor AR, Gupta A, Mittal P, Saini V, Jain J, Sanju S, Kapoor A, Giridhar P, Pujari L, Chowdhury Z, Gupta S (2024). Study protocol of Elective Para-aortic and pelvic versus Pelvic only Irradiation in pelvic node positive Cervical cancer: a multicentric open labelled phase III randomised controlled trial (EPIC Study). BMJ Open.14(11): .e08822
- 2. Noronha V, Menon N, Patil VM, Shah M, Joshi A, Shah S, Nawale K, Surve R, Bafna G, Jogdhankar S, Shelar P, Shetake A, Singh A, Salian S, Jadhav P, Shah H, Mer N, Vohra A, Majumdar S, Banavali S, Badwe R, Prabhash K (2024). Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial. British Journal of Cancer.
- 3. Gadewal N, Patidar D, Natu A, Gupta S, Bastikar V (2024). In silico screening of phytochemicals against chromatin modifier, SETD7 for remodeling of the immunosuppressive tumor microenvironment in renal cancer. Molecular Diversity.
- 4. Piñeros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, Mhatre S, Koshiol J, Bray F (2024). Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? International Journal of Cancer.
Video of the Week
Chemotherapy-induced Cachexia and Model-informed Dosing to Preserve Lean Mass in Cancer Treatment
Upcoming Events
11th - 12th December, 2024
At ACTREC, Tata Memorial Centre, Kharghar.
December 16-18, 2024
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
February 3-5, 2025
At SRM Institute of Science & Technology, Kattankulathur
Do You Know?
In 1958, scientist developed 5-fluorouracil (5-FU), a chemotherapy drug used to treat many cancers. It is a first-line treatment for colon cancer.
Cancer News
MedicalXpress, 28/11/2024
To investigate gliocidin's mechanism of action, researchers performed a genome-wide CRISPR–Cas9 knockout screen to identify genes that influence gliocidin's effectiveness against glioblastoma cells...
News-Medical, 26/11/2024
For the study, researchers performed a scan of 3,000 cancer cell genes known to be involved in cell metabolism to determine, by deletion, which were necessary for cancer cell survival after chemotherapy. Most of the genes they found that were essential to cell...
Nature Cancer, 25/11/2024
Relapse in T cell acute lymphoblastic leukemia (T-ALL) constitutes a challenge. A subclonal population of bone marrow progenitor-like cells present in all T-ALL genetic or immunophenotypic subtypes is now shown to confer chemoresistance and poor prognosis, and to be targetable with anti-apoptotic agents...
© 2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)